AI assistant
Biotest AG — Board/Management Information 2003
Oct 1, 2003
66_rns_2003-10-01_20466587-9006-44cc-803a-7ba97be6364f.html
Board/Management Information
Open in viewerOpens in your device viewer
News Details
Corporate | 1 October 2003 15:48
Biotest AG english
New chairman for the Biotest supervisory board Corporate-news announcement processed and sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– New chairman for the Biotest supervisory board Dreieich, October 1, 2003. The Frankfurt am Main local court has appointed Werner Spinner, from October 1, 2003 to be a member of the supervisory board of Biotest AG, a prime standard quoted company. He will succeed the current chairman of the supervisory board Dr. Hans Schleussner, who resigns because of his age at the same time. Mr. Spinner, who studied commerce at university, has comprehensive experience in both domestic and international health care business resulting from his employment at Bayer which lasted almost thirty years and where he has been a member of the management board for the last five years. The 54-year old is married and has four children. The Biotest AG supervisory board is expected to elect Werner Spinner as the chairman and Dr. Hans Schleussner as the honorary chairman on 17th October. On September 24, 2003, Dr. Schleussner was decorated with the Order of Merit of the Federal Republic of Germany for his outstanding achievements in scientific, cultural and social interests. Biotest was founded by Dr. Hans Schleussner and his father in 1946. Under the management of Dr. Hans Schleussner the pharmaceutical company achieved a global acting enterprise. Before elected as a chairman of the supervisory board in 1996, he was chairman of the board of management since the change into a public company in 1987. Biotest AG The Board of Managing Directors Biotest AG, Landsteinerstr. 5, D-63303 Dreieich, Germany For inquiries, please contact: Head of Publicity Hubert Bötsch Tel. +49 6103 801-444 Fax +49 6103 801-880 Email: [email protected] end of message, (c)DGAP 01.10.2003 ——————————————————————————– WKN: 522720; ISIN: DE0005227201; Index: Listed: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg und Stuttgart 011548 Okt 03